Puma Biotechnology Inc (PBYI)
4.76
-0.07
(-1.45%)
USD |
NASDAQ |
Apr 25, 10:24
Puma Biotechnology Cash from Investing (Quarterly): -8.17M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.17M |
| September 30, 2023 | 11.18M |
| June 30, 2023 | -4.683M |
| March 31, 2023 | -17.45M |
| December 31, 2022 | -11.87M |
| September 30, 2022 | 7.998M |
| June 30, 2022 | 1.997M |
| March 31, 2022 | 8.982M |
| December 31, 2021 | 4.621M |
| September 30, 2021 | -4.47M |
| June 30, 2021 | -5.731M |
| March 31, 2021 | -5.301M |
| December 31, 2020 | 10.82M |
| September 30, 2020 | -2.578M |
| June 30, 2020 | -9.219M |
| March 31, 2020 | 34.38M |
| December 31, 2019 | -0.432M |
| September 30, 2019 | 38.97M |
| June 30, 2019 | 11.21M |
| March 31, 2019 | -44.58M |
| December 31, 2018 | 2.582M |
| September 30, 2018 | -21.36M |
| June 30, 2018 | -38.80M |
| March 31, 2018 | -0.04M |
| December 31, 2017 | -23.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 44.08M |
| June 30, 2017 | 18.08M |
| March 31, 2017 | -54.07M |
| December 31, 2016 | 20.84M |
| September 30, 2016 | 29.47M |
| June 30, 2016 | 10.43M |
| March 31, 2016 | 81.46M |
| December 31, 2015 | 39.68M |
| September 30, 2015 | -4.746M |
| June 30, 2015 | -68.12M |
| March 31, 2015 | -52.68M |
| December 31, 2014 | 22.20M |
| September 30, 2014 | -2.771M |
| June 30, 2014 | -90.65M |
| March 31, 2014 | 7.943M |
| December 31, 2013 | 3.293M |
| September 30, 2013 | 2.227M |
| June 30, 2013 | -19.77M |
| March 31, 2013 | -27.28M |
| December 31, 2012 | -0.389M |
| September 30, 2012 | -0.011M |
| June 30, 2012 | -0.397M |
| March 31, 2012 | -0.424M |
| December 31, 2011 | -1.743M |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-17.45M
Minimum
Mar 2023
38.97M
Maximum
Sep 2019
3.171M
Average
-0.432M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.407M |
| Regeneron Pharmaceuticals Inc | -66.20M |
| Sarepta Therapeutics Inc | -64.36M |
| CytomX Therapeutics Inc | 12.87M |
| Mirum Pharmaceuticals Inc | -2.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.46M |
| Free Cash Flow | 14.37M |
| Free Cash Flow Per Share (Quarterly) | 0.2168 |
| Free Cash Flow to Equity (Quarterly) | 10.05M |
| Free Cash Flow to Firm (Quarterly) | 12.93M |
| Free Cash Flow Yield | 6.35% |